12:00 AM
Sep 30, 2013
 |  BioCentury  |  Emerging Company Profile

Symplmed: Skipping the middleman

Symplmed using online marketing platform to sell blood pressure meds

The broad availability of low cost generics and the size of salesforce needed to cover the market have made hypertension a no-fly zone for most biotechs and even some pharmas. Symplmed Pharmaceuticals LLC is entering the space, not with novel products, but with a web-based platform for selling drugs that is designed to improve patient adherence while reducing costs.

The test case for Symplmed's DyrctAxess marketing platform will be next month's launch of Aceon perindopril, a branded generic angiotensin-converting enzyme (ACE) inhibitor.

DyrctAxess provides direct distribution of the drugs from Symplmed to patients, with automatic refills and monitoring of patient-reported blood pressure.

"A physician will send the initial scrip directly to our distribution facility, so we then control and facilitate the fill and refill process," said President and CEO Erik Emerson.

Patients will need to register on a website to have the drugs shipped directly to them from...

Read the full 733 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >